A pharmaco-metabonomic study on chronic kidney disease and therapeutic effect of ergone by UPLC-QTOF/HDMS
about
Urinary metabolomics reveals the therapeutic effect of HuangQi Injections in cisplatin-induced nephrotoxic rats.Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathyMetabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosisUntargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120.Biodegradable Magnesium (Mg) Implantation Does Not Impose Related Metabolic Disorders in Rats with Chronic Renal FailureMetabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression.Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy.The Use of Omic Technologies Applied to Traditional Chinese Medicine ResearchA Chinese herbal formula, Jian-Pi-Yi-Shen decoction, improves muscle atrophy via regulating mitochondrial quality control process in 5/6 nephrectomised rats.Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease.The link between phenotype and fatty acid metabolism in advanced chronic kidney disease.Intestinal tract is an important organ for lowering serum uric acid in rats.DNA hypermethylation of sFRP5 contributes to indoxyl sulfate-induced renal fibrosis.Novel inhibitors of the cellular RAS components, Poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis.A GC-MS Based Metabonomics Study of Rheumatoid Arthritis and the Interventional Effects of the Simiaowan in Rats.Renoprotective effects of aliskiren on adenine-induced tubulointerstitial nephropathy: possible underlying mechanisms.Renoprotective effect of Zhenwu decoction against renal fibrosis by regulation of oxidative damage and energy metabolism disorderRhubarb Protect Against Tubulointerstitial Fibrosis by Inhibiting TGF-β/Smad Pathway and Improving Abnormal Metabolome in Chronic Kidney Disease
P2860
Q33804118-58685704-D72B-4979-8978-D81F09BA0FCBQ35926121-87D9E62C-83CD-474C-B4C0-CADFF7955722Q36100197-4C2CCA0A-FBD3-4A4B-B539-D13A68E5759FQ36638243-2F10BAA7-7758-4D37-90DC-96636F76C632Q36925093-95EC5E62-ADED-4328-9C1D-1222420F1C5FQ37343636-3620D053-FC1D-4404-88FC-9643B0BE478EQ37512208-5986954D-E3FD-4640-9AF5-88CE98F37CC7Q37640071-17A9E0C4-79AD-4338-8D15-0B1B750A1415Q38611121-A071BAEC-76AC-4FB2-9D74-B24FCE4F2F07Q41459702-50B1512C-87AE-48BF-ABED-92BE484C71EAQ46397367-18F2B8E7-689D-4A5D-AC59-999A28E6DFD1Q47265243-3148C303-685E-491D-8E3D-D41692070CA0Q50999594-DBA75DF3-4214-424D-AE0D-D72858919F67Q52573051-66C08878-5C4D-4695-BA47-4DC3AC98742CQ53394009-26A746B8-FB4C-4466-B11C-A24243863F5DQ53759933-EBFCF799-451E-4E8B-9EA5-52D99DC73687Q57050372-673D643B-014C-4C32-93F6-AB04F2F620B6Q57111037-48C3760E-2D06-460B-9708-56EF2FE4617D
P2860
A pharmaco-metabonomic study on chronic kidney disease and therapeutic effect of ergone by UPLC-QTOF/HDMS
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A pharmaco-metabonomic study o ...... ct of ergone by UPLC-QTOF/HDMS
@ast
A pharmaco-metabonomic study o ...... ct of ergone by UPLC-QTOF/HDMS
@en
type
label
A pharmaco-metabonomic study o ...... ct of ergone by UPLC-QTOF/HDMS
@ast
A pharmaco-metabonomic study o ...... ct of ergone by UPLC-QTOF/HDMS
@en
prefLabel
A pharmaco-metabonomic study o ...... ct of ergone by UPLC-QTOF/HDMS
@ast
A pharmaco-metabonomic study o ...... ct of ergone by UPLC-QTOF/HDMS
@en
P2093
P2860
P1433
P1476
A pharmaco-metabonomic study o ...... ct of ergone by UPLC-QTOF/HDMS
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0115467
P407
P577
2014-12-23T00:00:00Z